Melasma: Clinical Trials

8 trials for Melasma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 8

Follow Melasma: new trials by email Literature Review of Melasma trials Research Report on Melasma

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of New Trio Combination for Melasma
New trio combination, Kligman's formula (trio) - Melasma
Phase 4CompletedGhurki Trust and Teaching Hospital562025-05-072026-06-30
Evaluation of an Herbal-Based De-Pigmenting System
Herbal depigmenting agent (Epionce), Hydroquinone - Melasma, Hyperpigmentation
Phase 4CompletedSadick Research Group282013-10-012015-11-18
Ultraviolet and UV-Visible Light Photoprotection for the Treatment of Melasma
290-400 nm sunscreen, 290-800 nm sunscreen - Melasma
Phase 4CompletedUniversidad Autonoma de San Luis Potosí682012-09-012014-12-02
Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women
20-30% Salicylic Acid peels to the right side of the face, 20-30% Salicylic Acid peels to the left side of the face - Melasma
Phase 4CompletedUniversity of Texas Southwestern Medical Center202008-01-012020-08-10
Treatment of Melasma With Jessner's Solution vs. Trichloroacetic Acid
Jessner's solution chemical peel, Trichloroacetic acid chemical peel - Melasma
Phase 4CompletedEmory University192008-01-012013-11-14
Comparison of Two Tri-Luma® Maintenance Regimens in the Treatment of Melasma
Tri-Luma Maintenance regimen - Melasma
Phase 4CompletedGalderma R&D3402006-11-012021-02-17
Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma
Fluocinolone acetonide 0.1%/hydroquinone 4%/tretinoin 0.05% Cream in sequence with glycolic acid peels - Melasma
Phase 4CompletedGalderma R&D202006-11-012022-07-29
Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma
Fluocinolone acetonide .1%, hydroquinone 4%, tretinoin .05% - Melasma
Phase 4CompletedGalderma R&D702006-05-012022-07-29

Narrower conditions

Melanosis (8)  ·  Hyperpigmentation (1)

Broader conditions

Pigmentation Disorders (8)  ·  Skin Diseases (8)  ·  Skin and Connective Tissue Diseases (8)  ·  Hyperpigmentation (7)

Interventions

hydroquinone (3)  ·  Fluocinolone Acetonide (2)  ·  Base Sequence (1)  ·  Chemexfoliation (1)  ·  Proto-Oncogene Proteins c-raf (1)  ·  Shade UVAGuard (1)  ·  Sunscreening Agents (1)  ·  Tretinoin (1)  ·  Zinc Oxide (1)  ·  bis-ethylhexyloxyphenol methoxyphenyl triazine (1)  ·  drometrizole trisiloxane (1)  ·  ferric oxide (1)  ·  octocrylene (1)  ·  octyl triazone (1)  ·  octylmethoxycinnamate (1)

Sponsors

Galderma R&D (3)  ·  Emory University (1)  ·  Ghurki Trust and Teaching Hospital (1)  ·  Sadick Research Group (1)  ·  Universidad Autonoma de San Luis Potosí (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (5)  ·  Mexico (2)  ·  Brazil (1)  ·  Pakistan (1)

Top investigators

Ronald W Gottschalk, MD (2)  ·  Amit Pandya, M.D. (1)  ·  Bertha Torres-Alvarez, MD (1)  ·  Carl Washington, MD (1)  ·  Diana Hernandez-Blanco, MD (1)  ·  Dr Aliza Hamadani (1)  ·  Dr. Ayesha Asad Chattha (1)  ·  Dr. Iram Kausar (1)  ·  Dr. Meshaal Azhar (1)  ·  Juan P Castanedo-Cazares, MD (1)  ·  Neil S Sadick, MD (1)  ·  Prof. Dr. Haroon Nabi (1)

Results publications

PMID 20398959